Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSPIRE MEDICAL SYSTEMS, INC.

(INSP)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
12/01/2021 12/02/2021 12/03/2021 12/06/2021 12/07/2021 Date
225.17(c) 222.98(c) 207.57(c) 212.51(c) 222.85 Last
295 303 393 681 258 191 371 606 221 246 Volume
+0.85% -0.97% -6.91% +2.38% +4.87% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 221 M - -
Net income 2021 -53,0 M - -
Net cash position 2021 160 M - -
P/E ratio 2021 -109x
Yield 2021 -
Sales 2022 304 M - -
Net income 2022 -47,9 M - -
Net cash position 2022 129 M - -
P/E ratio 2022 -124x
Yield 2022 -
Capitalization 5 814 M 5 814 M -
EV / Sales 2021 25,6x
EV / Sales 2022 18,7x
Nbr of Employees 341
Free-Float 97,9%
More Financials
Company
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of invasive solutions for patients with obstructive sleep apnea (OSA). The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The therapy is indicated for patients... 
More about the company
Ratings of Inspire Medical Systems, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about INSPIRE MEDICAL SYSTEMS, INC.
11/17Inspire Medical Systems, Inc. to Present at the Piper Sandler 33rd Annual Healthcare Co..
AQ
11/10Inspire Medical Systems, Inc. Provides Update on 2022 Ambulatory Surgical Center Reimbu..
AQ
11/04Berenberg Bank Adjusts Inspire Medical Systems' Price Target to $267 From $218, Maintai..
MT
11/03INSPIRE MEDICAL SYSTEMS, INC. : Regulation FD Disclosure (form 8-K)
AQ
11/03Fresh data highlights strength of US economy ahead of Fed meeting
11/03Lake Street Adjusts Price Target on Inspire Medical Systems to $320 From $260, Maintain..
MT
11/03JPMorgan Adjusts Price Target on Inspire Medical Systems to $325 From $300, Maintains O..
MT
11/03ANALYST RECOMMENDATIONS : Avis Budget, DuPont de Nemours, Ingredion, Lyft, T-Mobile US...
11/03SVB Leerink Adjusts Inspire Medical Systems' Price Target to $325 from $300, Keeps Outp..
MT
11/03Wells Fargo Adjusts Price Target on Inspire Medical Systems to $305 From $250, Maintain..
MT
11/03Piper Sandler Adjusts Price Target on Inspire Medical Systems to $305 From $238, Mainta..
MT
11/02Inspire Medical Systems Narrows Q3 Loss on Rising Revenue, Ups Guidance -- Stock Rises ..
MT
11/02INSPIRE : Q3 Earnings Snapshot
AQ
11/02Inspire Medical Systems, Inc. Announces Third Quarter 2021 Financial Results and Update..
PU
11/02INSPIRE MEDICAL SYSTEMS, INC. Management's Discussion and Analysis of Financial Condit..
AQ
More news
News in other languages on INSPIRE MEDICAL SYSTEMS, INC.
11/02Inspire Medical Systems réduit sa perte au troisième trimestre grâce à l'augmentation d..
11/02Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS affiche un chiffre d'affaires de 61,7 mil..
11/02Inspire Medical Systems, Inc. révise ses prévisions de recettes pour l'année 2021
08/04Inspire Medical Systems affiche une perte plus étroite au deuxième trimestre, alors que..
08/03Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS annonce un chiffre d'affaires de 53 milli..
More news
Analyst Recommendations on INSPIRE MEDICAL SYSTEMS, INC.
More recommendations
Chart INSPIRE MEDICAL SYSTEMS, INC.
Duration : Period :
Inspire Medical Systems, Inc. Technical Analysis Chart | INSP | US4577301090 | MarketScreener
Technical analysis trends INSPIRE MEDICAL SYSTEMS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 212,51 $
Average target price 301,30 $
Spread / Average Target 41,8%
EPS Revisions
Managers and Directors
Timothy P. Herbert President, Chief Executive Officer & Director
Richard John Buchholz Chief Financial Officer
Marilyn Carlson Nelson Chairman
Quan Ni Vice President-Research & Clinical Affairs
Philip J. Ebeling Chief Operating Officer
Sector and Competitors